Shingrix® Shingles Vaccine Indicated for People 50 Years of Age and Older Zoster Vaccine Recombinant, Adjuvanted 50 mcg / 0.5 mL Injection Single-Dose Vial 0.5 mL

Compare

McKesson #

1081079

Manufacturer #

58160082311

Brand

Shingrix®

Manufacturer

Glaxo Smith Kline

Country of Origin

Unknown

Application

Shingles Vaccine

Container Type

Single-Dose Vial

Dosage Form

Injection

Generic Drug Code

43989

Generic Drug Name

Zoster Vaccine Recombinant, Adjuvanted

NDC Number

58160082311

Product Dating

McKesson Acceptable Dating: we will ship >= 180 days

Storage Requirements

Requires Refrigeration

Strength

50 mcg / 0.5 mL

Type

Intramuscular

UNSPSC Code

51201600

User

Indicated for People 50 Years of Age and Older

Volume

0.5 mL

SHINGRIX is a vaccine indicated for prevention of herpes zoster (shingles) in adults aged 50 years and older
SHINGRIX is not indicated for prevention of primary varicella infection (chickenpox)
SHINGRIX is a vaccine indicated for prevention of herpes zoster (shingles) in adults aged 18 years and older who are or will be at increased risk of HZ due to immunodeficiency or immunosuppression caused by known disease or therapy
SHINGRIX is supplied as 2 components: A single-dose vial of lyophilized gE antigen component (brown cap) and a single-dose vial of adjuvant suspension component (blue-green cap) (packaged without syringes or needles)
一个剂量fter reconstitution is 0.5 mL
Administer 2 doses (0.5 mL each) at 0 and 2 to 6 months
10 Doses